Supercritical Fluid Chromatography; Ultra High Performance Supercritical Fluid Chromatography; Ultra High Performance Liquid Chromatography; Quantitatives performances; Method Validation; Total error approach
Abstract :
[en] Recently, the number of papers about SFC increased drastically but scientists did not truly focus their work on quantitative performances of this technique. In order to prove the potential of UHPSFC, the present work discussed about the different steps of the analytical life cycle of a method: from development to validation and application. Moreover, the UHPSFC quantitative performances were evaluated in comparison with UHPLC, which is the main technique used for quality control in the pharmaceutical industry and then could be considered as a reference. The methods were developed using Design Space strategy, leading to the optimization of robust method. In this context, when the Design Space optimization shows guarantee of quality, no more robustness study is required prior to the validation. Then, the methods were geometrically transferred in order to reduce the analysis time. The UHPSFC and UHPLC methods were validated based on the total error approach using accuracy profile. Even if UHPLC showed better precision and sensitivity, UHPSFC method is able to give accurate results in a dosing range larger than the 80–120% range required by the European Medicines Agency. Consequently, UHPSFC results are valid and could be used for the control of active substance in a finished pharmaceutical product. Finally, UHPSFC validated method was used to analyse real samples and gave similar results than the reference method (UHPLC).
Research center :
Centre Interfacultaire de Recherche du Médicament - CIRM
Disciplines :
Chemistry
Author, co-author :
Dispas, Amandine ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Lebrun, Pierre ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Ziemons, Eric ; Université de Liège - ULiège > Département de pharmacie > Département de pharmacie
Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. J. Pharm. Biomed. Anal. 2004, 36:579. http://hdl.handle.net/2268/6169.
Hubert Ph., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L., Rozet E. J. Pharm. Biomed. Anal. 2007, 45:70. http://hdl.handle.net/2268/6170.
Hubert Ph., Nguyen-Huu J.-J., Boulanger B., Chapuzet E., Cohen N., Compagnon P.-A., Dewé W., Feinberg M., Laurentie M., Mercier N., Muzard G., Valat L., Rozet E. J. Pharm. Biomed. Anal. 2007, 45:82. http://hdl.handle.net/2268/41022.
Hubert Ph., Nguyen-Huu J.-J., Boulanger B., Chapuzet E., Cohen N., Compagnon P.-A., Dewé W., Feinberg M., Laurentie M., Mercier N., Muzard G., Valat L., Rozet E. J. Pharm. Biomed. Anal. 2008, 48:760. http://hdl.handle.net/2268/6171.
The International Conference of Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use; Q8 R2 Pharmaceutical Development,. http://www/ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_RI/Step4/Q8_R2_Guidelines.pdf.
Nethercote P., Ermer J. Pharm. Technol. 2012, 36:52.
Rozet E., Lebrun P., Debrus B., Boulanger B., Hubert P. TrAC 2013, 42:157. http://hdl.handle.net/2268/130125.
Borman P., Nethercote P., Chatfield M., Thompson D., Truman K. Pharm. Technol. 2007, 31:142.
Peterson J.J. What your ICH Q8 Design Space needs: a multivariate predictive distribution. Pharm. Manuf. Mag. 2010.